or
forgot password
  • cancer clinical trials in kansas city, MO

  • Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
    Saint Joseph Health Center

    Trial Locations
    Saint Joseph Health Center
    Liberty Radiation Oncology Clinic
    Heartland Hematology and Oncology Associates Incorporated
    Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma
    Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
    Saint Luke's Cancer Institute at Saint Luke's Hospital

    Trial Locations
    Saint Luke's Cancer Institute at Saint Luke's Hospital
    Research Medical Center
    Melanoma (Skin)
    Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
    North Kansas City Hospital

    Trial Locations
    North Kansas City Hospital
    Saint Luke's Cancer Institute at Saint Luke's Hospital
    Research Medical Center
    Parvin Radiation Oncology
    Chemotherapeutic Agent Toxicity, Fallopian Tube Cancer, Neurotoxicity, Ovarian Cancer, Pain, Peripheral Neuropathy, Primary Peritoneal Cavity Cancer
    Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin
    Research Medical Center

    Trial Locations
    Research Medical Center
    Saint Luke's Hospital of Kansas City
    Saint Joseph Health Center
    Truman Medical Center
    Heartland Hematology and Oncology Associates Incorporated
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    Study of Bone Marrow and Blood Samples in Patients With Untreated Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Enrolled on Clinical Trial CALGB-9621 or CALGB-9720
    Truman Medical Center - Hospital Hill

    Trial Locations
    Truman Medical Center - Hospital Hill
    St. Joseph Medical Center
    Heartland Hematology Oncology Associates, Incorporated
    North Kansas City Hospital
    Saint Luke's Cancer Institute at Saint Luke's Hospital
    Research Medical Center
    Leukemia
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    North Kansas City Hospital

    Trial Locations
    North Kansas City Hospital
    Saint Luke's Cancer Institute at Saint Luke's Hospital
    Research Medical Center
    Parvin Radiation Oncology
    Colorectal Cancer, Precancerous Condition
    Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Saint Luke's Hospital of Kansas City

    Trial Locations
    Saint Luke's Hospital of Kansas City
    Saint Joseph Health Center
    Truman Medical Center
    Heartland Hematology and Oncology Associates Incorporated
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma
    Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    North Kansas City Hospital

    Trial Locations
    North Kansas City Hospital
    Research Medical Center
    Saint Luke's Cancer Institute
    Saint Luke's Hospital of Kansas City
    Saint Joseph Health Center
    Liberty Radiation Oncology Clinic
    Truman Medical Center
    Heartland Hematology and Oncology Associates Incorporated
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    A Phase 2 Study of EZN-2208 in Patients With Metastatic Breast Cancer
    Location #14
    Kansas City, Missouri 64131
    Metastatic Breast Cancer
    Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma
    The Childrens Mercy Hospital
    Kansas City, Missouri 64108
    Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma
    Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer
    Kansas City Cancer Centers - North

    Trial Locations
    Kansas City Cancer Centers - North
    Kansas City Cancer Centers - South
    Lung Cancer
    Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide
    Children's Mercy Hospitals and Clinics
    Kansas City, Missouri 64108
    Neuroblastoma
    Survey of Inhibitors in Plasma-Product Exposed Toddlers
    Children's Mercy Hospital, Kansas City Regional Hemophilia Center
    Kansas City, Missouri 64108
    Hemophilia A
    Ixabepilone + Carboplatin Metastatic Breast Cancer
    Kansas City Cancer Center, LLC
    Kansas City, Missouri 64131
    Metastatic Breast Cancer
    A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
    Research Medical Center
    Kansas City, Missouri 64132
    Extensive-Stage Small Cell Lung Cancer
    Safety and Efficacy Study of Single Weekly Bortezomib in Newly Diagnosed Multiple Myeloma
    Kansas City VA Medical Center
    Kansas City, Missouri 64128
    Multiple Myeloma
    Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma
    North Kansas City Hospital

    Trial Locations
    North Kansas City Hospital
    Research Medical Center
    Saint Luke's Hospital of Kansas City
    Liberty Radiation Oncology Clinic
    Heartland Hematology and Oncology Associates Incorporated
    Burkitt Lymphoma, Diffuse Large B-cell Lymphoma, c-MYC Positive
    Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma
    Saint Luke's Hospital of Kansas City

    Trial Locations
    Saint Luke's Hospital of Kansas City
    Saint Joseph Health Center
    Heartland Hematology and Oncology Associates Incorporated
    Adenocarcinoma of the Extrahepatic Bile Duct, Adenocarcinoma of the Gallbladder, Adenocarcinoma With Squamous Metaplasia of the Gallbladder, Anaplastic Carcinoma of the Gallbladder, Cholangiocarcinoma of the Extrahepatic Bile Duct, Cholangiocarcinoma of the Gallbladder, Recurrent Extrahepatic Bile Duct Cancer, Recurrent Gallbladder Cancer, Unresectable Extrahepatic Bile Duct Cancer, Unresectable Gallbladder Cancer